Approval of Baclofen for Alcohol Use Disorders in France: A Perspective From the United States
Clicks: 235
ID: 271743
2020
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Emerging Content
7.5
/100
25 views
25 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
Approval of Baclofen for Alcohol Use Disorders in France: A Perspective From the United States
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (15 words).
Try re-searching for a better abstract.
| Reference Key |
jc2020alcoholapproval
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Garbutt JC;; |
| Journal | Alcohol and alcoholism (Oxford, Oxfordshire) |
| Year | 2020 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
humans
pubmed abstract
nih
national institutes of health
national library of medicine
female
male
United States
meta-analysis as topic
france
baclofen / therapeutic use*
alcoholism / drug therapy*
gaba-b receptor agonists / therapeutic use
pmid:31761948
doi:10.1093/alcalc/agz084
james c garbutt
drug approval*
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.